Skip to main content
editorial
. 2015 Oct 16;2:52. doi: 10.3389/fsurg.2015.00052

Figure 1.

Figure 1

(A) Tissue-engineered reconstructive solutions. (B) Potential barriers to translation at each level of the tissue-engineering supply chain.